Female Stress Urinary Incontinence Treatment Devices Market Size & Share, by Type (Urethral Sling, Artificial Urinary Sphincters, Electrical Stimulation Devices, Catheters); Product Type (Sling Systems, Pessaries, Injectable Urethral Bulking Agents); End-user (Hospitals, Gynecological Clinics, Home Care Settings) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

Global Female Stress Urinary Incontinence Treatment Devices Market Definition

The uncontrolled discharge of urine is known as urinary incontinence and can be triggered by laughing, sneezing, coughing, heavy lifting, running, and other physical movements. The common symptom of urinary incontinence is sudden leaks of urine by increased abdominal pressure. It generally occurs in females and can be treated with the help of electrical stimulation, surgery, vaginal inserts, and other behavioral therapies. In these surgeries, some of the equipment and devices are used such as injectable urethral bulking agents, sling systems, artificial urinary sphincters (AUS), pessaries, and others.

Before recommending any female stress urinary incontinence treatment devices, the healthcare providers study the medical history, conduct a physical examination and urinary stress test, and also include urine samples to look for any infections or other abnormalities. Additionally, tests for bladder functions such as measurements of post-void residual urine, cystoscopy, creating images of the bladder, measuring bladder pressures, and others are also included to recommend the most suitable stress urinary incontinence treatment devices. Mainly, two devices are provided for females that are urethral inserts and vaginal pessary.

The vaginal pessary is ring-shaped and has two bumps to be fixed on each side of the urethra. It is used to avoid any sort of urine leakage during physical activity that put pressure on the bladder. Urethral inserts are disposable tampon shapes devices that can be inserted in the urethra to provide a barrier so that unwanted urine leakage can be avoided.

Global Female Stress Urinary Incontinence Treatment Devices Market: Key Insights

Global Female Stress Urinary Incontinence Treatment Devices Market Size, Forecast, and Trend Highlights Over 2023 - 2033

The global female stress urinary incontinence treatment devices market is estimated to garner a revenue of ~ USD 1200 Million by the end of 2033 by growing at a CAGR of ~6% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of ~ USD 665 Million in the year 2022. The rise in the number of stress urinary incontinence treatment procedures and the higher number of women suffering from stress urinary incontinence is estimated to be the primary factor to hike the growth of the market over the forecast period. It was observed in 2019, over 28o,000 stress urinary incontinence procedures are performed per year worldwide. Generally, women develop stress urinary incontinence after giving birth and this disease can be an ignominious act for them. Hence, women suffering from it require stress urinary incontinence treatment procedures to prevent the symptoms and lead a normal life.

The rise of government initiatives to increase awareness of female stress urinary incontinence was predicted to drive the market's growth over the forecast period, among other trends in the global female stress urinary incontinence treatment devices market. For instance, the United States established a "Women's Health Awareness (WHA)" inside the National Institute of Environmental Health Sciences in order to deliver community-based evidence-based health care and boost community health resiliency. For women with stress urinary incontinence, devices such as urethral inserts have been found to be quite beneficial. These are the microscopic plugs that are put into the urethra during specific activities to stop urine flow. As a result, during the anticipated period, these factors are anticipated to boost the market growth.

Global Female Stress Urinary Incontinence Treatment Devices Market: Growth Drivers and Challenges

Growth Drivers

• Increase in Instances of Urinary Incontinence – The incidence of urinary incontinence in women ranged between 10%-65% across the globe while the symptoms of this disease are observed to escalate with age, for instance, nearly 70% of women aged above 65 report urine leakage.

Urinary incontinence is a condition in which the person losses the control over bladder and people are not much open-minded about this disease. Hence a higher number of women are in the need of proper treatment to cure this condition which is expected to propel the growth of the market over the forecast period.

• Rising Prevalence of Gynecological Disorders – In India alone, the percentage of women diagnosed with PCOS was estimated to be nearly 9% in 2021 while more than 12% of women in the United States suffer from it.

• Growing Incidence of Urinary Incontinence Due to Menopause – Each year about 1 million women attain menopause in the U.S.

• Rise in Incidence of Tuberculosis – As of 2020, the number of tuberculosis cases per 100,000 individuals was estimated to be around 7,174 globally.

• Increase of Medical Conditions such as Parkinson’s Disease, and Multiple Sclerosis – As the global estimates in 2019, over 8.5 million people have Parkinson’s disease which is further projected to be doubled in 25 years.

Challenges

• Emergence of Neuromodulator for Electric Stimulation of Nerves
• Limitation in Patients with the Fibrotic Urethra
• Poor Procedural Outcomes

It is not necessary to get rid of stress urinary incontinence after receiving the proper treatment and the patients might have to continue taking the medicines or drugs. Hence, such uncertainty about the treatment is expected to hamper the growth of the market over the forecast period.

Global Female Stress Urinary Incontinence Treatment Devices Market Segmentation

The global female stress urinary incontinence treatment devices market is segmented and analyzed for demand and supply by end-user in hospitals, gynecological clinics, and home care settings. Out of these end users, the hospital segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the presence of developed healthcare infrastructure and the availability of a huge medical force, labs, and other equipment in a single place. The total number of all U.S hospitals was estimated to be about 6,093 in 2022. Whereas, in the type segment, the electrical stimulation devices sub-segment holds the largest market share of 54.42% as of 2022, owing to their ease of operation, and cost-effectiveness with the great convenience of being self-administered at home. Furthermore, hospitals are noticed to provide better medical care for women with PCOS. For instance, it has been observed that around 20% of women globally get hospitalized owing to PCOS.

The global female stress urinary incontinence treatment devices market is also segmented and analyzed for demand and supply by type into the urethral sling, artificial urinary sphincters, electrical stimulation devices, and catheters. Amongst these segments, the urethral sling segment is expected to garner a significant share. A urethral sling is a surgery that is performed to treat to treat stress urinary incontinence. The sling is placed in the urethra to support it and to carry urine from the bladder to discharge it. It is observed that approximately 75% of incontinence cases are completely cured after surgery while many cases don’t even require sling surgery. Hence, such factors are expected to hike the growth of the segment over the forecast period.

Our in-depth analysis of the global female stress urinary incontinence treatment devices market includes the following segments: 

Global Female Stress Urinary Incontinence Treatment Devices Market Regional Synopsis

The North American female stress urinary incontinence treatment devices market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033. The growth of the market can be attributed majorly to the well-established healthcare infrastructure boosted by investment and growing R&D of drugs and medications. The healthcare spending of the U.S. in 2020 was USD 4000 billion. Furthermore, growing cases of stress urinary incontinence in the region owing to several regions backed by the presence of female stress urinary incontinence treatment device manufacturers are expected to expand the market size during the forecast period. Stress urinary incontinence is a disease that requires immediate medical attention. For instance, approximately 22 million American suffer from stress urinary incontinence and around 80% of them are women. Additionally, in every 3 women in the region, 1 of them has faced SUI in her life. Hence, all these factors are estimated to propel the growth of the market over the forecast period.

Furthermore, the Asia Pacific region is anticipated to obtain the second-largest share of the market during the forecast period. The growth of the market is attributed to the increased prevalence of overactive bladder and urinary incontinence among women in urban and rural settings, decreased access to adequate healthcare services, a decreased propensity to seek treatment, growing awareness of the various diagnostic and treatment options, and rising preference for minimally invasive treatments for Urinary Incontinence.

Top Featured Companies Dominating the Global Female Stress Urinary Incontinence Treatment Devices Market

• Boston Scientific Corporation
  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis

• Johnson & Johnson Services, Inc.
• Becton, Dickinson and Company
• Coloplast Corp.
• CooperSurgical, Inc.
• MedGyn Products, Inc.
• Caldera Medical, Inc
• FEG Textiltechnik mbH
• Medical Device Business Services, Inc.
• Renovia Inc.